Invesco
IMRX icon

Invesco’s Immuneering IMRX Stock Holding History

Invesco’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$156K Buy
+31,176
New +$158K ﹤0.01% 3656
2023
Q4 		– Sell
-10,249
Closed -$78.7K – 3861
2023
Q3 		$78.7K Buy
10,249
+24
+0.2% +$221 ﹤0.01% 3753
2023
Q2 		$104K Buy
+10,225
New +$98.3K ﹤0.01% 3719

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Invesco's IMRX Position: Q2 2026 in Review

Invesco opened a new position in Immuneering (IMRX) in Q2 2026: 31,176 shares worth $156K. The stake represents ﹤0.01% of the portfolio and ranks #3656 among its holdings. This is a return to the name: Invesco previously reported a position in IMRX as recently as Q3 2023.

Invesco first reported a position in IMRX in Q2 2023 and has held it in 3 quarters since. 112 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Invesco held 31,176 shares of Immuneering worth $156K as of Q2 2026.
  • Immuneering was a new Invesco position in Q2 2026.
  • Immuneering made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3656 holding.
  • Invesco first reported a position in Immuneering in Q2 2023 and has held it in 3 quarters since.
  • 112 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.